General MedicationsORALStandard
RIVAROXABAN
RIVAROXABAN
Standard Dose
20MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview RIVAROXABAN is listed in Drugs@FDA under application 219332 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient RIVAROXABAN Form and strength TABLET;ORAL - 20MG Sponsor ASCENT PHARMS INC Submission history Latest submission status date: 2025-05-14 00:00:00.
Structured Monograph
Clinical summary
Approval overview RIVAROXABAN is listed in Drugs@FDA under application 219332 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient RIVAROXABAN Form and strength TABLET;ORAL - 20MG Sponsor ASCENT PHARMS INC Submission history Latest submission status date: 2025-05-14 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.